Clear All
12159 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00310-1349-30 00310-1349 Osimertinib Tagrisso 40.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral Nov 13, 2015 In Use
00143-9565-01 00143-9565 Thiotepa Thiotepa 15.0 mg/1.5mL Chemotherapy Alkylating Agent Nitrogen Mustard /Ethylenimine Intracavitary, Intravenous, Intravesical Jun 1, 2001 In Use
71288-0172-92 71288-0172 Oxaliplatin Oxaliplatin 5.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Jan 11, 2024 In Use
00002-5337-54 00002-5337 Abemaciclib Verzenio 150.0 mg/1 Chemotherapy Cyclin Dependent Kinase Inhibitor CDK 4/6 Oral Oct 6, 2017 In Use
61703-0349-09 61703-0349 Irinotecan Hydrochloride Irinotecan Hydrochloride 20.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Feb 27, 2008 In Use
16729-0049-53 16729-0049 Temozolomide Temozolomide 20.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Mar 7, 2017 In Use
63629-1472-03 63629-1472 Methotrexate sodium Methotrexate Sodium 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Apr 19, 2010 In Use
00009-0082-02 00009-0082 Irinotecan hydrochloride Camptosar 20.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Jun 24, 2024 In Use
10019-0926-02 10019-0926 Ifosfamide Ifosfamide 3.0 g/60mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Dec 30, 1988 In Use
00078-0649-30 00078-0649 Imatinib Mesylate Gleevec 400.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Dec 23, 2014 Dec 31, 2026 In Use
67457-0476-10 67457-0476 Oxaliplatin Oxaliplatin 100.0 mg/20mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Aug 9, 2012 Dec 31, 2017 No Longer Used
00054-0482-13 00054-0482 Everolimus Everolimus 10.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Dec 7, 2021 In Use
68001-0265-27 68001-0265 Etoposide Etoposide 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Nov 14, 2013 In Use
67457-0455-52 67457-0455 Cytarabine Cytarabine 100.0 mg/5mL Chemotherapy Antimetabolite Pyrimidine Analog Intrathecal, Intravenous, Subcutaneous Dec 14, 2011 Oct 31, 2022 No Longer Used
68083-0177-01 68083-0177 Oxaliplatin Oxaliplatin 5.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Nov 6, 2017 In Use
63323-0174-20 63323-0174 Ifosfamide Ifosfamide 50.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Sep 30, 2009 Jul 31, 2012 No Longer Used
62484-1020-04 62484-1020 MERCAPTOPURINE MERCAPTOPURINE 20.0 mg/mL Chemotherapy Antimetabolite Purine Analog Oral Sep 8, 2025 In Use
70860-0200-05 70860-0200 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Mar 24, 2017 Dec 31, 2024 No Longer Used
59651-0241-30 59651-0241 Imatinib Mesylate Imatinib Mesylate 400.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Jul 23, 2020 In Use
50242-0717-01 50242-0717 Cobimetinib Cotellic 20.0 mg/1 Chemotherapy MAPK/MEK Inhibitor BRAF Oral Nov 10, 2015 In Use
75007-0501-32 75007-0501 Bortezomib Bortezomib 3.5 mg/1 Chemotherapy Proteasome Inhibitor 26S Intravenous, Subcutaneous Dec 17, 2025 In Use
51862-0083-14 51862-0083 Temozolomide Temozolomide 5.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Oct 10, 2016 Sep 30, 2019 No Longer Used
00085-1417-02 00085-1417 Temozolomide Temodar 250.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug 11, 1999 In Use
63323-0125-53 63323-0125 GEMCITABINE GEMCITABINE 1.0 g/25mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jul 26, 2011 In Use
55150-0452-01 55150-0452 MITOMYCIN MITOMYCIN 40.0 mg/80mL Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous Oct 30, 2023 In Use

Found 12159 results — Export these results